BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23125418)

  • 1. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
    Simpson KD; Templeton DJ; Cross JV
    J Immunol; 2012 Dec; 189(12):5533-40. PubMed ID: 23125418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation.
    Jia X; Xi J; Tian B; Zhang Y; Wang Z; Wang F; Li Z; Long J; Wang J; Fan GH; Li Q
    Cancer Immunol Res; 2024 Jan; 12(1):72-90. PubMed ID: 37956411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
    Coleman AM; Rendon BE; Zhao M; Qian MW; Bucala R; Xin D; Mitchell RA
    J Immunol; 2008 Aug; 181(4):2330-7. PubMed ID: 18684922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
    Cox GM; Kithcart AP; Pitt D; Guan Z; Alexander J; Williams JL; Shawler T; Dagia NM; Popovich PG; Satoskar AR; Whitacre CC
    J Immunol; 2013 Aug; 191(3):1043-54. PubMed ID: 23797673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
    Alban TJ; Bayik D; Otvos B; Rabljenovic A; Leng L; Jia-Shiun L; Roversi G; Lauko A; Momin AA; Mohammadi AM; Peereboom DM; Ahluwalia MS; Matsuda K; Yun K; Bucala R; Vogelbaum MA; Lathia JD
    Front Immunol; 2020; 11():1191. PubMed ID: 32625208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
    Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.
    Yaddanapudi K; Putty K; Rendon BE; Lamont GJ; Faughn JD; Satoskar A; Lasnik A; Eaton JW; Mitchell RA
    J Immunol; 2013 Mar; 190(6):2984-93. PubMed ID: 23390297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice.
    Choi S; Kim HR; Leng L; Kang I; Jorgensen WL; Cho CS; Bucala R; Kim WU
    J Immunol; 2012 Oct; 189(8):3905-13. PubMed ID: 22972922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
    Zhang M; Yan L; Kim JA
    Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
    Heinrichs D; Knauel M; Offermanns C; Berres ML; Nellen A; Leng L; Schmitz P; Bucala R; Trautwein C; Weber C; Bernhagen J; Wasmuth HE
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17444-9. PubMed ID: 21969590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation.
    Atsumi T; Cho YR; Leng L; McDonald C; Yu T; Danton C; Hong EG; Mitchell RA; Metz C; Niwa H; Takeuchi J; Onodera S; Umino T; Yoshioka N; Koike T; Kim JK; Bucala R
    J Immunol; 2007 Oct; 179(8):5399-406. PubMed ID: 17911626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.
    Alexander JK; Cox GM; Tian JB; Zha AM; Wei P; Kigerl KA; Reddy MK; Dagia NM; Sielecki T; Zhu MX; Satoskar AR; McTigue DM; Whitacre CC; Popovich PG
    Exp Neurol; 2012 Aug; 236(2):351-62. PubMed ID: 22575600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer.
    Jäger B; Klatt D; Plappert L; Golpon H; Lienenklaus S; Barbosa PD; Schambach A; Prasse A
    Cell Signal; 2020 Sep; 73():109672. PubMed ID: 32428553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.
    Parker KH; Horn LA; Ostrand-Rosenberg S
    J Leukoc Biol; 2016 Sep; 100(3):463-70. PubMed ID: 26864266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
    Pasqualon T; Lue H; Groening S; Pruessmeyer J; Jahr H; Denecke B; Bernhagen J; Ludwig A
    Biochim Biophys Acta; 2016 Apr; 1863(4):717-26. PubMed ID: 26852939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.